Partnerships

Arrowhead Research

Arrowhead Research Corporation provides executive and operational management, as well as financial, accounting and administrative services to Leonardo Biosystems, Inc. Arrowhead is a nanomedicine company focused on the development of innovative treatments for cancer and obesity, and is a minority stockholder of Leonardo. This arrangement enables Leonardo to draw on the expertise of experienced professionals across a broad range of disciplines at relatively low cost.

NanoMedical Systems

NanoMedical Systems (NMS) and Leonardo have entered into a development agreement whereby NMS will establish a commercial process to manufacture nanoporous silicon particles for Leonardo's multi-stage drug delivery system. NMS brings to the partnership expertise in the fabrication of massively-parallel nanofluidic structures in silicon gained in the development of their own drug delivery products. With the support of university researchers and NMS, Leonardo has formed prototype particles, demonstrating all the necessary unit processes to make the particles. Under the collaboration, NMS will engineer, refine, and integrate these steps in a manner that prepares Leonardo for manufacturing particles suitable for clinical trials. In addition, their medical device engineering quality system is designed to produce an FDA-compliant manufacturing process which should be fully scalable during development and, ultimately, marketing.